Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege European Journal of Dermatology · 2014 · 10 citations
2. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
3. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
4. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
5. Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review) Molecular Medicine Reports · 2010 · 21 citations
6. The influence of interferon on healthy and diseased skin Cytokine · 2018 · 32 citations
7. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
8. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C Journal of Clinical Virology · 2014 · 11 citations
9. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005 · 27 citations
10. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area Journal of the European Academy of Dermatology and Venereology · 2008 · 34 citations

Community

— no results